Blog
Fentanyl Analogue Identification Toolkit Aids Forensic Toxicology
BlogGetting an arrow in the target is hard enough but imagine trying to do it when the target is constantly moving or morphs into something that doesn’t even look like the target anymore? This is the challenge for forensic scientists trying to detect fentanyl in samples. We spoke to research scientist Alex Krotulski about his group’s arms race with the evolution of fentanyl variants.
Read More
Waters’ Highly Flexible SYNAPT XS Offers Freedom of Analytical Choice
BlogA highly flexible and high-resolution mass spectrometer, the SYNAPT™ XS technology from Waters has been developed with the analytical needs of R&D labs in mind. Joanne Ballantyne tells us more about the development of SYNAPT™ XS and the features to which it lends its versatility.
Read More
NRGene Are Taking Agricultural Research to the MAX
BlogNRGene recently announced the launch of DeNovoMAX, an enhanced version of its flagship product DeNovoMAGIC, for whole genome assembly. As part of the DeNovo assembly product suite, DeNovoMAX aims to take agricultural research further by empowering breeding and maximizing agricultural yield. We spoke with Gal Ramot, Marketing Director at NRGene Ltd to learn about the applications of DeNovoMAX and how it has been built to crack the most "complex of genomes".
Read More
Pharma-backed Toolkit to Speed Up Adoption of FAIR Data Principles
BlogFAIR is a set of data principles that hopes to form a gold standard for scientific data management. Non-profit the Pistoia Alliance has developed a toolkit to help companies adopt FAIR. We spoke to Pistoia's Ian Harrow to find out more.
Read More
Therapeutically Targeting DYRK1A in Alzheimer’s Disease
BlogAlzheimer’s disease (AD) is a neurodegenerative condition. There are currently no FDA-approved disease‐modifying therapies for AD, despite it being the most common cause of dementia. We recently spoke with Samumed’s CEO Osman Kibar, to learn more about the company's efforts to therapeutically target "DYRK1A" in AD.
Read More
Identifying Novel Opioid Agonists From Metabolites
BlogNovel drugs of abuse have been a growing problem for law enforcement and the medical profession. Consequently, they have also become a challenge for analysts in the face of new or variant chemicals. We spoke to Research Scientist Alex Krotulski about the work he is doing to identify new and emerging illicit substances.
Read More
When Science Leaves the Lab, Microscopy Goes Portable
BlogMicroscopy is a key tool in many areas of research, but what happens when what you want to study is in a remote location, doesn’t transport well or you need instant answers? Well, then the analysis has to go to the sample. We spoke to Andrew Monk, cofounder of ioLight, about ioLight’s conception and what makes it so special.
Read More
The Steps to Creating a Materials Informatics Strategy
BlogData has been called the crucial raw material of the 21st century. As such, materials companies are waking up to the importance of having an informatics strategy. We caught up with Lux Research's Xiao Zhong, Ph.D., who recently authored a report explaining the key steps in creating a materials informatics strategy, to find out more.
Read More
Wellness and Illness From a Precision Quantification Perspective
BlogIn this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.
Read More
A Step Towards Democratization in Mass Spectrometry: Agilent Launch Novel "Self-aware" Mass Detector
BlogHow can vendors ensure their technologies are less complex, and therefore available to a wider range of users, without compromising on the quality of data?
Read More
